361 related articles for article (PubMed ID: 11014233)
21. Downregulation of calcitonin receptor mRNA expression by calcitonin during human osteoclast-like cell differentiation.
Takahashi S; Goldring S; Katz M; Hilsenbeck S; Williams R; Roodman GD
J Clin Invest; 1995 Jan; 95(1):167-71. PubMed ID: 7814611
[TBL] [Abstract][Full Text] [Related]
22. A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro.
Quinn JM; Elliott J; Gillespie MT; Martin TJ
Endocrinology; 1998 Oct; 139(10):4424-7. PubMed ID: 9751528
[TBL] [Abstract][Full Text] [Related]
23. Control of cyclic adenosine 3',5'-monophosphate production in osteoclasts: calcitonin-induced persistent activation and homologous desensitization of adenylate cyclase.
Nicholson GC; Moseley JM; Yates AJ; Martin TJ
Endocrinology; 1987 May; 120(5):1902-8. PubMed ID: 3032571
[TBL] [Abstract][Full Text] [Related]
24. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
25. Divergent structural requirements exist for calcitonin receptor binding specificity and adenylate cyclase activation.
Houssami S; Findlay DM; Brady CL; Martin TJ; Epand RM; Moore EE; Murayama E; Tamura T; Orlowski RC; Sexton PM
Mol Pharmacol; 1995 Apr; 47(4):798-809. PubMed ID: 7723741
[TBL] [Abstract][Full Text] [Related]
26. Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells.
Kondo H; Guo J; Bringhurst FR
J Bone Miner Res; 2002 Sep; 17(9):1667-79. PubMed ID: 12211438
[TBL] [Abstract][Full Text] [Related]
27. Effects of interleukin 3 and of granulocyte-macrophage and macrophage colony stimulating factors on osteoclast differentiation from mouse hemopoietic tissue.
Hattersley G; Chambers TJ
J Cell Physiol; 1990 Jan; 142(1):201-9. PubMed ID: 2153687
[TBL] [Abstract][Full Text] [Related]
28. Activated T lymphocytes suppress osteoclastogenesis by diverting early monocyte/macrophage progenitor lineage commitment towards dendritic cell differentiation through down-regulation of receptor activator of nuclear factor-kappaB and c-Fos.
Grcević D; Lukić IK; Kovacić N; Ivcević S; Katavić V; Marusić A
Clin Exp Immunol; 2006 Oct; 146(1):146-58. PubMed ID: 16968409
[TBL] [Abstract][Full Text] [Related]
29. Androgens suppress osteoclast formation induced by RANKL and macrophage-colony stimulating factor.
Huber DM; Bendixen AC; Pathrose P; Srivastava S; Dienger KM; Shevde NK; Pike JW
Endocrinology; 2001 Sep; 142(9):3800-8. PubMed ID: 11517156
[TBL] [Abstract][Full Text] [Related]
30. Long-term dose- and time-dependent effects of endodontic sealers in human in vitro osteoclastogenesis.
Rodrigues C; Costa-Rodrigues J; Capelas JA; Fernandes MH
J Endod; 2013 Jun; 39(6):833-8. PubMed ID: 23683288
[TBL] [Abstract][Full Text] [Related]
31. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
[TBL] [Abstract][Full Text] [Related]
32. Prostaglandin E2 stimulates osteoclast-like cell formation and bone-resorbing activity via osteoblasts: role of cAMP-dependent protein kinase.
Kaji H; Sugimoto T; Kanatani M; Fukase M; Kumegawa M; Chihara K
J Bone Miner Res; 1996 Jan; 11(1):62-71. PubMed ID: 8770698
[TBL] [Abstract][Full Text] [Related]
33. Evidence that human cartilage and chondrocytes do not express calcitonin receptor.
Lin Z; Pavlos NJ; Cake MA; Wood DJ; Xu J; Zheng MH
Osteoarthritis Cartilage; 2008 Apr; 16(4):450-7. PubMed ID: 17890110
[TBL] [Abstract][Full Text] [Related]
34. 12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation.
Wang C; Steer JH; Joyce DA; Yip KH; Zheng MH; Xu J
J Bone Miner Res; 2003 Dec; 18(12):2159-68. PubMed ID: 14672351
[TBL] [Abstract][Full Text] [Related]
35. Calcitonin-induced changes in the cytoskeleton are mediated by a signal pathway associated with protein kinase A in osteoclasts.
Suzuki H; Nakamura I; Takahashi N; Ikuhara T; Matsuzaki K; Isogai Y; Hori M; Suda T
Endocrinology; 1996 Nov; 137(11):4685-90. PubMed ID: 8895334
[TBL] [Abstract][Full Text] [Related]
36. Comparisons between the effects of calcitonin receptor-stimulating peptide and intermedin and other peptides in the calcitonin family on bone resorption and osteoclastogenesis.
Granholm S; Henning P; Lerner UH
J Cell Biochem; 2011 Nov; 112(11):3300-12. PubMed ID: 21748786
[TBL] [Abstract][Full Text] [Related]
37. Calcitonin down-regulates immediate cell signals induced in human osteoclast-like cells by the bone sialoprotein-IIA fragment through a postintegrin receptor mechanism.
Paniccia R; Riccioni T; Zani BM; Zigrino P; Scotlandi K; Teti A
Endocrinology; 1995 Mar; 136(3):1177-86. PubMed ID: 7867571
[TBL] [Abstract][Full Text] [Related]
38. Calcitonin receptors as markers for osteoclastic differentiation: correlation between generation of bone-resorptive cells and cells that express calcitonin receptors in mouse bone marrow cultures.
Hattersley G; Chambers TJ
Endocrinology; 1989 Sep; 125(3):1606-12. PubMed ID: 2547591
[TBL] [Abstract][Full Text] [Related]
39. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
Valverde P; Tu Q; Chen J
J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
[TBL] [Abstract][Full Text] [Related]
40. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
